Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 29 July 2009, doi:10.1136/bmj.b3071
Cite this as: BMJ 2009;339:b3071
Nayanah Siva
1 London
| The first 150 words of the full text of this article appear below. |
A top orthopaedic surgeon from the University of California, Los Angeles (UCLA) has been demoted after failing to disclose financial links with the medical companies whose products he was researching.
The Wall Street Journal (http://online.wsj.com, 22 Jul, "Surgeon faces probe of research") reports that Jeffrey Wang allegedly failed to tell the university about payments of $459 500 he received between 2004 and 2007 from the companies. Charles Grassley, the US Republican senator who has pursued unreported payments by drug companies to doctors and researchers, is said to have written to the universitys vice chancellor about the payments.
Professor Wang was removed from his position as director of UCLAs Comprehensive Spine Center. He remains at the university but is currently undergoing an internal investigation by the university.
In a statement the university said: "UCLA has appointed an independent committee charged with reviewing whether any of the potential conflicts-of-interests identified
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?